<--- Back to Details
First PageDocument Content
Medicine / Cancer / Clinical medicine / Papillomavirus / Vaccines / RTT / Infectious causes of cancer / Immunology / Virus-like particle / HPV vaccines / Immunogenicity / Human papillomavirus infection
Date: 2012-07-09 16:50:03
Medicine
Cancer
Clinical medicine
Papillomavirus
Vaccines
RTT
Infectious causes of cancer
Immunology
Virus-like particle
HPV vaccines
Immunogenicity
Human papillomavirus infection

The UNM Interdisciplinary HPV Prevention Center

Add to Reading List

Source URL: hpvprevention.unm.edu

Download Document from Source Website

File Size: 274,22 KB

Share Document on Facebook

Similar Documents

Medicine / Cancer / Clinical medicine / Papillomavirus / Vaccines / RTT / Infectious causes of cancer / Immunology / Virus-like particle / HPV vaccines / Immunogenicity / Human papillomavirus infection

The UNM Interdisciplinary HPV Prevention Center

DocID: 1rtWC - View Document

Medicine / Clinical medicine / Immunology / Cancer treatments / Virotherapy / Virus-like particle / Immunotherapy / Vaccine

IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

DocID: 1qztD - View Document

Medicine / Microbiology / Veterinary medicine / Biological weapons / Tropical diseases / Zoonoses / Ebola / Animal virology / Ebola virus / VSV-EBOV / VP40 / Virus-like particle

SUPPLEMENT ARTICLE Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles Osvaldo Martinez,1,a Lee Tantral,1,a Nirupama Mulherkar,2 Kartik Chandran,2 and Christoph

DocID: 1q28Y - View Document

Biotechnology / Polyomaviridae / Infectious causes of cancer / Molecular biology / Major capsid protein VP1 / Virus-like particle / Recombinant DNA / Virus / VP1 / Monoclonal antibody / Protein production

Department of Eukaryote Genetic Engineering Senior Scientist and Head Gintautas Žvirblis, PhD

DocID: 1pIGC - View Document

Immunology / Cancer treatments / Virotherapy / Virus-like particle / Immunotherapy / Vaccine

IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

DocID: 1ovZf - View Document